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Abstract
Background: Around two thirds stroke patients may suffer from vascular cognitive impairment (VCI). Our previous
study has validated the NINDS-CSN harmonization standard for VCI diagnosis in Chinese. In this study, we aimed to
investigate the predictors for VCI in Chinese post-stroke patients.
Methods: We compared epidemiological, clinical, and neuroimaging data (number, size and location of acute
infarcts and lacunes, severities of white matter hyperintensities and brain atrophy) between stroke patients with
and without VCI. Univariate and logistic regression analyses were utilized to determine VCI predictors.
Results: Fifty-six consecutive patients (age, 63.8 ± 8.3 years; female, 37.5 %) were recruited at a mean interval of 7.
1 months after stroke onset, and 31 (55.4 %) patients were diagnosed with VCI based on a validated 60-min
neuropsychological battery. VCI patients were older (p = 0.023), less educated (p = 0.001), more likely to be female
(p < 0.001), had a recurrent stroke (p = 0.028), and described higher apathy (p = 0.022) and worse pre-stroke
cognition (p = 0.048) than cognitively normal patients. Lower educational level (adjusted odds ratio [OR] 0.750,
95 % confidence interval [CI], 0.573–0.981; p = 0.035), female sex (adjusted OR 8.288, 95 % CI, 1.522–45.113; p = 0.
014), recurrent stroke (adjusted OR 11.327, 95 % CI, 1.335–96.130, p = 0.026), and global cortical atrophy (adjusted
OR 5.730, 95 % CI, 1.128–29.101, p = 0.035) were independently associated with VCI in post-stroke patients.
Conclusions: Lower education, female sex, recurrent stroke and global cortical atrophy were associated with VCI in
Chinese stroke patients.
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Background
Stroke survivors are prone to develop cognitive impair-
ment, with a frequency of 62.6 % at 3 months post-
stroke [1], and persisted long-term functional effects [2].
This prolonged cognitive sequela of stroke has been
widely used to study vascular cognitive impairment
(VCI). However, most studies have either focused on de-
mentia [3], or used diverse diagnostic criteria with vari-
ous cognitive scales [4]. In 2006, the National Institute
of Neurological Disorders and Stroke and Canadian
Stroke Network (NINDS-CSN) established common
standards for VCI assessments [5], and our previous
work validated the Chinese adaption of neuropsycho-
logical scales in mild stroke patients [6].
VCI may result directly from an acute stroke or from
underlying chronic brain lesions, such as white matter
hyperintensities (WMHs) and subclinical lacunes [7].
However, the predictors for VCI in post-stroke patients
was equivocal [3, 8, 9]. In some studies, WMHs [3, 8],
lacunes [10, 11], silent brain infarctions [12], and brain
atrophy [3, 10] had been associated with VCI after
stroke. However, others reported that large infarcts were
associated with greater likelihood of cognitive dysfunc-
tion, but found no significant effect of WMHs, silent in-
farcts or cerebral atrophy in predicting post-stroke VCI
[13], or had not found any significant association after
multivariable adjustment [12, 14].
Although VCI used to be diagnosed only in the
context of a cerebral infarction, recent studies have
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highlighted the importance of pre-existing brain lesions
as a key determinant for incident VCI in post-stroke pa-
tients [3, 8]. Moreover, in the investigation of factors re-
lated to VCI development, few studies have applied a
population-validated NINDS-CSN neuropsychological
protocol to VCI diagnosis [1]. To investigate the predic-
tors for post-stroke VCI, we collected epidemiological,
clinical and neuroimaging data in detail. We hypothe-
sized that chronic brain lesions (e.g., old infarcts,
WMHs, and brain atrophy) would be significant predic-
tors of the development of VCI after stroke.
Methods
Participants
Participants were consecutive patients with an MRI scan
for an acute ischemic stroke, aged 50 years or older, ad-
mitted to a teaching hospital from January to June 2013.
Additional inclusion criteria for neuropsychological
assessment were an available informant who was
knowledgeable with the patient’s cognitive performance
on a daily or next to daily basis for at least 10 years prior
to recruitment, informed consent, and absence of severe
motor and language disabilities hindering cognitive
evaluation. Exclusion criteria for this study were a his-
tory of hemorrhagic stroke, traumatic brain injury, Par-
kinson disease, psychiatric disorders known to influence
cognitive function, or a pre-existing cognitive impair-
ment according to the Informant Questionnaire on Cog-
nitive Decline in the Elderly (IQCODE), a screening
instrument validated in Chinese, scoring 3.4 or more
[15]. The institutional review board at Jinling Hospital
approved the study, and all participants provided written
informed consent.
Neuropsychological assessment
Patients’ cognitive and psychological status was assessed
at 3 to 12 months after stroke, using the 60-min Chinese
version of NINDS-CSN neuropsychological protocol.
The protocol examined the following four cognitive do-
mains: executive/activation (animal naming [16], WAIS-
III Digit symbol-coding [17], trail making test, parts A
and B [18]), language (modified Boston naming test
[19]), visuoconstruction (Rey-Osterrieth Complex Figure
Test [RCFT]-copy trial [20]), and memory (delayed re-
call on the revised Hopkins verbal learning test [21] and
RCFT [20]). Besides, the Chinese version of Mini-
Mental State Examination (MMSE) and the Montreal
Cognitive Assessment (MoCA), Beijing version were
evaluated to test global cognitive function; the Geriatric
Depression Scale (GDS) and the Apathy Evaluation Scale
(AES) were used to assess depressive and apathetic
symptoms, respectively; the Neuropsychiatric Inventory
Questionnaire (NIQ) was administered to probe behav-
ioral domains; and the IQCODE was also completed by
the informant to obtain the pre-morbid history of cogni-
tive status. All neuropsychological tests were adminis-
tered in each subject’s primary language of Mandarin
Chinese. For each domain, cognitive impairment was
identified if more than half of the tests had a score >1.5
SD below age and education matched means of controls
[6]. For example, the executive/activation domain con-
sisted of 4 tests, and was classified as having an abnor-
mal function if patients scored >1.5 SD below the means
on at least 2 tests. The subject was categorized as a VCI
patient when cognitive impairment was observed in at
least one domain, and in the absence of pre-stroke cog-
nitive impairment.
Medical history
We retrospectively collected data on demographics and
clinical factors regarding the index event from medical
records. Basic information included age, sex, years of
education, and body mass index. Vascular risk factors
that we recorded included hypertension (defined as
presenting with a history of hypertension, or under anti-
hypertensive treatment), diabetes mellitus (defined by
fasting plasma glucose ≥7.0 mmol/L, or 2-h postprandial
glucose ≥11.1 mmol/L, or the use of insulin/oral
hypoglycemic medication), hyperlipidemia (defined as
total cholesterol ≥5.2 mmol/L, or low-density lipoprotein
cholesterol ≥2.6 mmol/L, or triglyceride ≥1.70 mmol/L,
or being treated with lipid-lowering drugs), atrial fibrilla-
tion (diagnosed according to electrocardiogram), ische-
mic heart disease (defined as a history of myocardial
infarction or angina pectoris), recurrent stroke, smoking,
and current alcohol use (drinking >2 units per day). In
addition, stroke subtype (Trial of Org 10172 in Acute
Stroke Treatment, TOAST criteria) and severity (Na-
tional Institutes of Health Stroke Scale, NIHSS score) of
stroke were also recorded.
Neuroimaging examination
Routine non-contrast brain computed tomography was
initially performed. All patients underwent brain MRI on
a 1.5-T or 3.0-T scanner (GE Healthcare, Milwaukee,
WI, USA), including sequences of axial T1-weighted
imaging (TR/TE = 350/2.5 ms), axial T2-weighted im-
aging (TR/TE = 4000/98 ms), diffusion-weighted imaging
(DWI) (TR/TE = 3000/91 ms), and coronal T2 fluid-
attenuated inversion recovery (FLAIR) (TR/TE = 8000/
93 ms), with slice thickness 5 mm, spacing between
slices 6.5 mm, field of view 90.625 mm for T1/T2-
weighted imaging, 100 mm for DWI and 81.25 mm for
FLAIR, and matrix of 320 × 260, 512 × 416, 256 × 256
and 512 × 464 for T1, T2-weighted imaging, DWI and
FLAIR, accordingly. All MRI images were read by X. C.
who was blinded to subjects’ clinical or neuropsycho-
logical information.
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The assessment of acute and chronic brain lesions
were based on MRI. An acute infarction was defined as
a lesion that showed DWI hyperintensity with corre-
sponding apparent diffusion coefficient hypointensity
[22]. Acute ischemic characteristics with regard to in-
farct number, size and location were collected. Lesion
size was recorded in maximum axial diameter by using
the built-in software Numaris/4 (syngo MR B17; Sie-
mens). Lesion locations were classified as frontal lobe,
parieto-occipital lobe, temporal lobe, basal ganglia, thal-
amus or the infratentorial area. WMHs were visually
rated on T2-weighted and FLAIR images using the age-
related white matter change (ARWMC) scale [23]. Large
and small old infarcts evident on MRI were recorded.
Small old infarcts, termed as lacunes, were CSF-like le-
sions of between 3 mm and 15 mm in diameter, with a
surrounding rim of hyperintensity on FLAIR and T1-
weighted images [24]. Brain atrophy was estimated by a
4-point rating scale for the assessment of global cortical
atrophy (GCA) [25], and a 5-point rating scale for med-
ial temporal lobe atrophy (MTA) [26], with GCA being
defined as 1 point or more and MTA ≥2 points. The
presence of cerebral artery stenosis was determined by
magnetic resonance angiography, computed tomography
angiography, or digital subtraction angiography.
To test intra-rater agreement of the neuroimaging
evaluation, 10 randomly selected scans were re-read by
the same rater (X. C.), blinded to previous rating scores.
The intra-rater agreement was then assessed using intra-
class correlation coefficients (ICC).
Statistical analysis
Descriptive statistics were calculated for demographics,
clinical, and neuroimaging variables in patients with and
without VCI. Group comparisons of categorical variables
were performed with the χ2 test, and comparisons of
continuous variables were done by the independent sam-
ple t test, or Mann–Whitney U test in case of skewed
distributions. Effect sizes were estimated in a common
form of Cohen’s d, and the intervals for Cohen’s d were:
0–0.1, no effect; 0.2–0.4, small effect; 0.5–0.7, intermedi-
ate effect; 0.8 and higher: strong effect [27]. Variables
that were important risk factors for VCI based on prior
knowledge, except those highly correlated, were intro-
duced as independent variables in multivariate stepwise
logistic regression analysis. p < 0.05 indicated statistical
significance. All analyses were performed using the SPSS
Statistics for Windows, version 17.0.
Results
Between January and June 2013, 165 stroke patients with
MRI scans were screened, of whom 56 patients under-
went neuropsychological assessments (mean age, 63.8 ±
8.3 years, 37.5 % were women). Median NIHSS score on
admission was 3 (interquartile range [IQR], 1–5.75). The
interval between stroke onset and cognitive assessment
was 7.1 months (SD = 2.3), while the interval between
MRI examination and cognitive assessment was
6.9 months (SD = 2.3). Comparisons were made between
patients with (n = 31, 55.4 %) and without (n = 25,
44.6 %) VCI.
Table 1 compared the demographics, risk factors, and
stroke features between the two groups. VCI patients
were older, less educated, more likely to be female, and
more likely to have a recurrent stroke than cognitively
normal patients. No between-group differences were ob-
served in terms of stroke subtype, stroke severity and
other vascular risk factors. The onset-to-test time was
similar between groups.
Comparisons of neuropsychological assessments be-
tween stroke patients with and without VCI were pre-
sented in Table 2. Patients with VCI scored worse than
those without VCI on individual tests. Global cognitive
functioning, as assessed by MMSE and MoCA, was also
significantly worse in patients with VCI. Emotional tests
indicated that VCI patients described higher apathy than
cognitively normal patients. Pre-stroke cognitive status
as measured by the IQCODE was also worse for the VCI
group (p = 0.048, cohen’s d = 0.55). The patients with
cognitive impairment were impaired on the executive/
activation domain at a percentage of 67.7 %, on the lan-
guage domain of 45.2 %, on the visuoconstruction do-
main of 64.5 %, and on the memory domain of 77.4 %;
besides, 12.9 % of the patients were impaired on a single
domain. By the MMSE cutoff points for cognitive im-
pairment (17/18 for illiterates, 19/20 for individuals with
1 to 6 years of education, and 24/25 for those with 7 or
more), only 19.4 % of the patients were below the cutoff.
The neuroimaging features in each group were dis-
played in Table 3. The reproducibility after a mean dur-
ation of 34.5 days (SD = 5.8) showed excellent intra-rater
agreement in rating WMHs by ARWMC total score
(ICC, 0.871; 95 % confidence interval [CI], 0.482–0.968),
and MTA (ICC, 0.947; 95 % CI, 0.786–0.987) and
GCA(ICC, 0.957; 95 % CI, 0.827–0.989). By group com-
parisons, a trend was noted in VCI patients with regard
to larger acute lesions, more old infarcts, larger lacunar
sizes and greater GCA (cohen’s d ranged from 0.42 to
0.48). However, ARWMC total score, MTA, and loca-
tions of acute and chronic lesions (effect sizes ranged
from 0.02 to 0.40) showed no differences between
groups (Additional file 1).
To explore the independent association of acute or
chronic brain lesions with VCI, we chose important vari-
ables based on prior knowledge, including age, sex, edu-
cation, hypertension, diabetes, recurrent stroke, lacunar
number/lacunar size, ARWMC score, presence of MTA,
GCA, AES and GDS score, into a multivariate logistic
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regression model (Table 4). Lower educational level
(odds ratio [OR] 0.750, 95 % confidence interval [CI],
0.573–0.981; p = 0.035), female sex (OR 8.288, 95 % CI,
1.522–45.113; p = 0.014), a recurrent stroke (OR 11.327,
95 % CI, 1.335–96.130, p = 0.026), and global cortical at-
rophy (OR 5.730, 95 % CI, 1.128–29.101, p = 0.035) were
identified as independent predictors for post-stroke VCI.
Discussion
This study suggested that risk factors for VCI in post-
stroke patients included lower education, female sex, re-
current stroke and global cortical atrophy.
Stroke serves as an important factor in VCI. In our
study, 55.4 % of the stroke patients suffered VCI, which
was lower than that (62.6 %) of a recent study in Korea
[1]. However, participants in our study had a longer
interval between neuropsychological tests and stroke
(7.1 months vs. 3 months), which could possibly allow
stroke recovery. Evaluations took place 3 to 12 months
after stroke onset. Therefore, some participants were
further along in their recovery than others. While onset-
to-test time did not vary between patients with and
without VCI, a long time span may have reduced the
sensitivity of the neuropsychological tests.
Recurrent stroke was an independent risk factor for
VCI in our study, paralleling previous findings that
recurrent stroke would at least double the rates of de-
mentia than first-ever stroke [28]. The underlying mech-
anism may be that an increased volume of brain injury
would reduce the threshold for manifestation of subclin-
ical neurodegenerative disorders. Compared with cogni-
tively normal patients, VCI patients tended to show a
larger infarct size with a medium effect size of the differ-
ences. Earlier studies had generally shown an inconsist-
ent relationship between size and number of infarcts
and cognitive impairment [3, 13], this could possibly be
explained by the uncertainty of cortical involvement,
and differences in distribution of hypoperfusion [7].
Though cortical involvement was considered to be asso-
ciated with more impaired cognitive function [13], the
scientific evidence for it was rare and conflicting. One
recent studies showed a comparable performance be-
tween cortical and subcortical infarctions [29], and our
study did not show between-group differences regarding
lesion locations as well. Nevertheless, these findings
Table 1 Clinical characteristics comparing patients with and without VCI after stroke
Characteristics Patients without VCI (n = 25) Patients with VCI (n = 31) p value Cohen’s d
Demography
Age (years)a 61.0 ± 6.9 66.0 ± 8.8 0.023 0.63
Sex (female) 3 (12.0 %) 18 (58.1 %) <0.001 1.07
Education (years)a 11.2 ± 3.7 7.5 ± 4.3 0.001 0.92
Body mass index (kg/m2)a 24.8 ± 2.3 25.6 ± 4.0 0.416 0.25
Vascular risk factors
Hypertensionb 19 (76.0 %) 27 (87.1 %) 0.281 0.29
Diabetes mellitusb 10 (40.0 %) 13 (41.9 %) 0.884 0.04
Hyperlipidemiab 19 (76.0 %) 22 (71.0 %) 0.672 0.11
Atrial fibrillationb 1 (4.0 %) 1 (3.2 %) 0.698 0.04
Ischemic heart diseaseb 4 (16.0 %) 2 (6.5 %) 0.237 0.31
Current/former smokerb 16 (64.0 %) 13 (41.9 %) 0.100 0.45
Alcohol abuseb 7 (28.0 %) 3 (9.7 %) 0.075 0.49
Recurrent strokeb 2 (8.0 %) 10 (32.3 %) 0.028 0.62
Stroke subtype by TOAST 0.592 0.38
Large-artery atherosclerosisb 10 (40.0 %) 17 (54.8 %)
Small-artery occlusionb 10 (40.0 %) 11 (35.5 %)
Cardioembolismb 1 (4.0 %) 1 (3.2 %)
Undetermined causeb 4 (16.0 %) 2 (6.5 %)
Stroke severity
NIHSS scorea 3.2 ± 3.2 4.4 ± 3.7 0.236 0.35
Onset-to-test time (months)a 6.7 ± 2.3 7.4 ± 2.4 0.294 0.30
TOAST trial of org 10172 in acute stroke treatment, NIHSS National Institute of Health stroke scale
amean ± SD, independent sample t test
bnumber (%), χ2 test
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were based on a cross-sectional design, and how the
change of an acute lesion over time could affect cogni-
tive progression could be further explored.
The role of chronic brain lesions on the development
of post-stroke VCI was substantial [7]. Patients with
lacunes have been reported to have poorer performance
in multiple cognitive domains and steeper decline in
cognitive function in different cohorts, such as the Car-
diovascular Health Study, the Rotterdam Study and the
Epidemiology of Dementia in Singapore study [10–12].
Our study likewise indicated a trend of association be-
tween lacunar size and VCI. The possible explanation
was that an increase in lacunar volume was associated
with decline in executive function [30], besides, it was
demonstrated that the silent lacunar infarct was related
to cortical atrophy, which may also impair cognition
[10]. Recent surveys underlined the importance of
WMHs, MTA as independent risk factors for VCI after
stroke [3, 8], but in this study, VCI patients did not show
an association with WMHs or MTA. This might be due
to the exclusion of patients with pre-stroke cognitive im-
pairment in our study; for individuals with more severe
WMHs and more atrophy are prone to display a worsen-
ing of cognitive ability, which could account for their ap-
parent associations with post-stroke VCI [7]. Severe
WMHs were mainly associated with frontal lobe dys-
function, which was considered to be a consequence of
damaged neural transmission and interneural connec-
tion, however, novel evidence implicated that the effects
of WMHs on cognitive performance might be mediated
by cortical thickness [31]. Therefore, in some reports,
more extensive WMHs were shown to be related to cog-
nitive impairment, but the association did not persist in
multivariate modeling [12, 14]. Another study from
Finland also suggested a loss of significance for the cor-
relation between MTA and post-stroke dementia after
excluding individuals with pre-stroke dementia [32].
In this study, female sex and education were independ-
ently associated with VCI in post-stroke patients, con-
curring with previous findings [33, 34]. Female sex may
play a role in poststroke cognitive impairment by related
degenerative pathology, which would interact with vas-
cular pathology as well [35], and unsurprisingly, greater
prestroke cognitive decline was observed in VCI patients
in our study. The beneficial effect of education could be
that a higher education level indicated better cognitive
reserve, in this way, patients with higher reserve would
show an altered, compensatory network to maintain
function in the face of age-related pathophysiological
changes [36].
Table 2 Comparison of neuropsychological assessments between patients with and without VCI after stroke
Neuropsychological tests Patients without VCI (n = 26) Patients with VCI (n = 31) p value Cohen’s d
Executive/Activation
ANTa 16.0 ± 3.8 11.6 ± 4.2 <0.001 1.10
WAIS-III Digit symbol-codinga 20.6 ± 4.5 10.8 ± 5.8 <0.001 1.86
TMT A time (sec)a 43.4 ± 9.8 111.5 ± 74.2 <0.001 1.29
TMT B time (sec)a 104.5 ± 31.0 200.7 ± 78.4 <0.001 1.62
Language
Modified BNTa 11.4 ± 2.1 8.2 ± 2.4 <0.001 1.42
Visuospatial
RCFT copya 34.7 ± 1.2 28.1 ± 7.0 <0.001 1.31
Memory
HVLT-R delayed recalla 7.0 ± 2.3 3.3 ± 2.1 <0.001 1.70
RCFT delayed recalla 19.0 ± 4.7 9.8 ± 7.3 <0.001 1.50
Supplemental tests
MMSE scorea 28.1 ± 1.3 24.6 ± 3.2 <0.001 1.43
MoCA scorea 22.7 ± 3.2 16.4 ± 4.4 <0.001 1.64
GDS scorea 2.7 ± 1.9 3.9 ± 4.1 0.146 0.38
AES scorea 59.4 ± 5.7 54.4 ± 9.3 0.022 0.65
NIQ scoreb 9 (0.5–16.0) 4 (0–20.0) 0.714 0.10
IQCODEa 3 (3.0–3.1) 3.1 (3.0–3.2) 0.048 0.55
ANT Animal naming test, TMT trail making test, BNT Boston naming test, RCFT rey-osterrieth complex figure test, HVLT-R revised Hopkins verbal learning test,
MMSE mini-mental state examination MoCA montreal cognitive assessment, GDS geriatric depression scale, AES apathy evaluation scale, NIQ neuropsychiatric
inventory questionnaire
amean ± SD, independent sample t test
bmedian (IQR), Mann–Whitney U test
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Various definitions of VCI would hinder its identifica-
tion. Based on the common standards proposed by the
NINDS-CSN, our study may be one of the first studies
using population validated criteria for VCI diagnosis
[1, 5]. Besides, this study will in part contribute to a
future meta-analysis on the subject whether patients
with cognitive impairment were associated with direct
infarct lesions, or the underlying chronic brain lesions.
Limitations of the study were as follows. First, this was
a single-center study, the sample size was small and was
heterogeneous with regard to age, stroke subtype, and
cognitive status, limiting the statistical power, and in-
creasing the possibility of type II errors. Thus, null find-
ings with meaningful effect sizes such as larger size of
acute infarct and lacunes, and cortical atrophy, may be
negatively affected due to low statistical power. Second,
the study sample was hospital-based and most patients
suffered a relatively mild stroke, so our results may not
generalize to those with more severe or very mild stroke,
or to those who show specific cognitive deficits (e.g.,
aphasia) that precluded proper cognitive assessment.
Third, pre-stroke cognitive status was merely measured
by IQCODE due to the cross-sectional nature, hence pa-
tients with subtle cognitive impairment may be included.
Fourth, both 1.5 T and 3.0 T MRIs were used, which
could introduce magnetic bias for their sensitivity to le-
sions may be different. Fifth, we measured MTA, GCA
and WMHs using visual rating scale, and lacunes by size
Table 3 Comparison of neuroimaging features between patients with and without VCI after stroke
Neuroimaging features Patients without VCI (n = 25) Patients with VCI (n = 31) p value Cohen’s d
Patients with acute lesiona 24 (96.0 %) 31 (100.0 %) 0.446 0.30
No. of acute lesionsb 1 (1–2.0) 1 (1–3.0) 0.184 0.36
Lesion size (mm)c 19.0 ± 11.3 26.0 ± 20.5 0.112 0.42
Chronic brain changes
Patients with large old infarcta 1 (4.0 %) 6 (19.4 %) 0.091 0.47
Patients with lacunesa 18 (72.0 %) 25 (80.6 %) 0.446 0.20
No. of lacunesc 3.0 ± 3.3 4.4 ± 4.2 0.180 0.37
Lacunar size (mm)c 5.7 ± 4.3 7.6 ± 4.48 0.107 0.44
ARWMC total scorec 5.6 ± 3.8 6.6 ± 4.0 0.338 0.26
Presence of MTAa,d 5 (20.0 %) 4 (12.9 %) 0.360 0.19
Presence of GCAa,e 7 (28.0 %) 15 (48.4 %) 0.120 0.48
Artery stenosis 0.247 0.56
No stenosisa 6 (24.0 %) 4 (12.9 %)
Intracranial stenosisa 12 (48.0 %) 20 (64.5 %)
Extracranial stenosisa 7 (28.0 %) 5 (16.1 %)
Tandem stenosisa,f 0 2 (6.5 %)
Stenosis severity 0.666 0.12
Nonea 6 (24.0 %) 4 (12.9 %)
Mild stenosis (0–50 %)a 7 (28.0 %) 7 (22.6 %)
Moderate stenosis (50 %–70 %)a 2 (8.0 %) 6 (19.4 %)
Severe stenosis (70–99 %)a 2 (8.0 %) 9 (29.0 %)
Occlusiona 8 (32.0 %) 5 (16.1 %)
ARWMC age-related white matter change scale, MTA medial temporal lobe atrophy, GCA global cortical atrophy
anumber (%), χ2 test
bmedian (IQR), Mann–Whitney U test
cmean ± SD, independent sample t test
dPresence of MTA was defined as a rating of 2 points or more
ePresence of GCA was defined as a rating of 1 point or more
fTandem stenosis was defined as more than one stenotic lesion with severity ≥50 % in the same vascular distribution
Table 4 Risk factors associated with VCI in multivariate logistic
regression
Risk factors Odds ratio 95 % Confidence interval p value
Education 0.750 0.573–0.981 0.035
Female sex 8.288 1.522–45.113 0.014
Recurrent stroke 11.327 1.335–96.130 0.026
Presence of GCA 5.730 1.128–29.101 0.035
Model adjusted for age, hypertension, diabetes, lacunar number/lacunar size,
age-related white matter change score, medial temporal lobe atrophy, apathy
and depression scores
GCA global cortical atrophy
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and number rather than quantitative calculation, further
larger, multi-center studies that use automated unbiased
measurements are needed to confirm the observations
in the present study.
Conclusion
In conclusion, lower education, female sex and recurrent
stroke were predictors for VCI in Chinese post-stroke
patients. Chronic brain lesions such as lacunes and cor-
tical atrophy might be potential imaging biomarkers of
VCI, which could be examined in future studies. In
addition, effort should be made to optimize secondary
stroke prevention and to increase cognitive reserve, for
the purpose of delaying the clinical expression of VCI.
Further preclinical studies are warranted to investigate
the underlying pathogenesis as well as targeted interven-
tions in long term VCI prevention and treatment.
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